Maike Scherf-Clavel

18PUBLICATIONS
42CO-AUTHORS
PharmacogenomicsToxicology (incl. clinical toxicology)Clinical pharmacology and therapeuticsPsycholinguistics (incl. speech production and comprehension)Psychosocial aspects of childbirth and perinatal mental health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 02, 2026
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2026 - Pharmacokinetic, pharmacogenetic and clinical aspects.

|Jun 26, 2026
Preliminary Evidence for Sex Differences in CYP2C19 Metabolic Capacity During Psychotropic Drug Treatment.

|Apr 09, 2026
Influence of combined CYP2C19 and CYP2D6 phenotypes on adverse drug reactions in patients with major depressive disorder: a clinical cohort study.

Carolin Görnert, Maike Scherf-Clavel, Heike Weber

|Mar 02, 2026
Serum Concentration-Dependent Inhibition of CYP2D6 by Bupropion and Doxepin: Implications for Venlafaxine and Risperidone Metabolism.

Georgios N Zioris, Bodo Warrings, Jürgen Deckert

|Dec 19, 2025
The Effect of Kidney Function and Cardiovascular and Anti-Inflammatory Comedications on the Serum Concentration of Risperidone under Naturalistic Conditions.

Meike Kohler, Jürgen Deckert, Sebastian Walther

|Oct 14, 2025
Off-label drug use in children and adolescents treated with antidepressants and antipsychotics: results from a prospective multicenter trial.

Regina Taurines, Manfred Gerlach, Christoph U Correll

Pageof 3

Frequent Collaborators

4 joint publications

Stefanie Fekete

4 joint publications

Karin M Egberts

3 joint publications

Martina Hahn

3 joint publications

Heike Weber